COMP <GO>
VIRC vs PG // EV/EBITDA & P/E VALUATION
Virco Manufacturing Corporation (NASDAQ) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: VIRC 1
— PG 11
▲ EV/EBITDA & P/E VALUATION LEADER: VIRC
LAST: $6.20 (-0.48%) • MKT CAP: $97.7M
valuation
10.1x
LAST: $161.57 (+0.61%) • MKT CAP: $374.48B
valuation
16.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VIRC VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VIRC | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 40.70% | 51.20% | -10.50 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.00% | 25.40% | -22.40 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 10.1x | 16.2x | -6.10 | VIRC | /valuation <GO> |
| Free Cash Flow Yield | -6.82% | 3.77% | -10.59 | PG | /fcf-yield <GO> |
| Operating Margin | 1.80% | 24.30% | -22.50 | PG | /operating-margins <GO> |
| Net Profit Margin | 1.30% | 19.00% | -17.70 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | -25.00% | 0.30% | -25.30 | PG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.60% | 2.65% | -1.05 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 5.59 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.1 | 62.0 | -18.90 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 35.5x | 21.7x | +13.80 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $97.7M | $374.48B | -$374.39B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VIRC REV | PG REV | VIRC GROSS % | PG GROSS % | VIRC FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $199.7M | $84.28B | 40.7% | 51.2% | -$6.7M | $14.04B |
| FY 2024 | $266.2M | $84.04B | 43.1% | 51.4% | $26.8M | $16.52B |
| FY 2023 | $269.1M | $82.01B | — | — | $27.0M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VIRC // BETA —
PG // BETA 0.87